APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-iodinated X-ray Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-iodinated X-ray Contrast Agents Market Analysis and Forecast 2026-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchNon-iodinated X-ray Contrast Agents Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-iodinated X-ray Contrast Agents Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Non-iodinated X-ray Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-iodinated X-ray Contrast Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-iodinated X-ray Contrast Agents Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non-iodinated X-ray Contrast Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non-iodinated X-ray Contrast Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-iodinated X-ray Contrast Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-iodinated X-ray Contrast Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-iodinated X-ray Contrast Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Non-iodinated X-ray Contrast Agents include Bracco Diagnostics, Guerbet Group, Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qingdao Hongdie New Materials Co., Ltd., Shandong Shengli Pharmaceutical Co., Ltd., Taishan Xinning Pharmaceutical Co., Ltd. and Xi'an Disai Biopharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non-iodinated X-ray Contrast Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-iodinated X-ray Contrast Agents, also provides the sales of main regions and countries. Of the upcoming market potential for Non-iodinated X-ray Contrast Agents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-iodinated X-ray Contrast Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-iodinated X-ray Contrast Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non-iodinated X-ray Contrast Agents sales, projected growth trends, production technology, application and end-user industry.

Non-iodinated X-ray Contrast Agents Segment by Company

Bracco Diagnostics

Guerbet Group

Qinhuangdao Zizhu Pharmaceutical Co., Ltd.

Qingdao Hongdie New Materials Co., Ltd.

Shandong Shengli Pharmaceutical Co., Ltd.

Taishan Xinning Pharmaceutical Co., Ltd.

Xi'an Disai Biopharmaceutical Co., Ltd.

Non-iodinated X-ray Contrast Agents Segment by Type

Barium Sulfate Type I

Barium Sulfate Type II

Non-iodinated X-ray Contrast Agents Segment by Application

Hospital

Clinic

Other

Non-iodinated X-ray Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-iodinated X-ray Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-iodinated X-ray Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-iodinated X-ray Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Non-iodinated X-ray Contrast Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Non-iodinated X-ray Contrast Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-iodinated X-ray Contrast Agents sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-iodinated X-ray Contrast Agents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Barium Sulfate Type I Major Manufacturers Table 3. Barium Sulfate Type II Major Manufacturers Table 4. Global Non-iodinated X-ray Contrast Agents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Non-iodinated X-ray Contrast Agents Industry Trends Table 9. Non-iodinated X-ray Contrast Agents Industry Drivers Table 10. Non-iodinated X-ray Contrast Agents Industry Opportunities and Challenges Table 11. Non-iodinated X-ray Contrast Agents Industry Restraints Table 12. Global Non-iodinated X-ray Contrast Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Non-iodinated X-ray Contrast Agents Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Non-iodinated X-ray Contrast Agents Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Region (2021-2026) Table 16. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Region (2027-2032) Table 17. Global Non-iodinated X-ray Contrast Agents Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Non-iodinated X-ray Contrast Agents Sales by Region (2021-2026) & (K Units) Table 19. Global Non-iodinated X-ray Contrast Agents Sales by Region (2027-2032) & (K Units) Table 20. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Region (2021-2026) Table 21. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Region (2027-2032) Table 22. Global Non-iodinated X-ray Contrast Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Non-iodinated X-ray Contrast Agents Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Manufacturers (2021-2026) Table 26. Global Non-iodinated X-ray Contrast Agents Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Non-iodinated X-ray Contrast Agents Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Non-iodinated X-ray Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Non-iodinated X-ray Contrast Agents Manufacturers, Product Type & Application Table 30. Global Non-iodinated X-ray Contrast Agents Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Non-iodinated X-ray Contrast Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Non-iodinated X-ray Contrast Agents Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Non-iodinated X-ray Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Type (2021-2026) Table 37. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Type (2027-2032) Table 38. Global Non-iodinated X-ray Contrast Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 40. Global Non-iodinated X-ray Contrast Agents Sales by Type (2027-2032) & (K Units) Table 41. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Type (2021-2026) Table 42. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Type (2027-2032) Table 43. Global Non-iodinated X-ray Contrast Agents Price by Type (2021-2026) & (US$/Unit) Table 44. Global Non-iodinated X-ray Contrast Agents Price by Type (2027-2032) & (US$/Unit) Table 45. Global Non-iodinated X-ray Contrast Agents Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Non-iodinated X-ray Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Application (2021-2026) Table 49. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Application (2027-2032) Table 50. Global Non-iodinated X-ray Contrast Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 52. Global Non-iodinated X-ray Contrast Agents Sales by Application (2027-2032) & (K Units) Table 53. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Application (2021-2026) Table 54. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Application (2027-2032) Table 55. Global Non-iodinated X-ray Contrast Agents Price by Application (2021-2026) & (US$/Unit) Table 56. Global Non-iodinated X-ray Contrast Agents Price by Application (2027-2032) & (US$/Unit) Table 57. Bracco Diagnostics Company Information Table 58. Bracco Diagnostics Business Overview Table 59. Bracco Diagnostics Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Bracco Diagnostics Non-iodinated X-ray Contrast Agents Product Portfolio Table 61. Bracco Diagnostics Recent Development Table 62. Guerbet Group Company Information Table 63. Guerbet Group Business Overview Table 64. Guerbet Group Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Guerbet Group Non-iodinated X-ray Contrast Agents Product Portfolio Table 66. Guerbet Group Recent Development Table 67. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Company Information Table 68. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Business Overview Table 69. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 71. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Recent Development Table 72. Qingdao Hongdie New Materials Co., Ltd. Company Information Table 73. Qingdao Hongdie New Materials Co., Ltd. Business Overview Table 74. Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 76. Qingdao Hongdie New Materials Co., Ltd. Recent Development Table 77. Shandong Shengli Pharmaceutical Co., Ltd. Company Information Table 78. Shandong Shengli Pharmaceutical Co., Ltd. Business Overview Table 79. Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 81. Shandong Shengli Pharmaceutical Co., Ltd. Recent Development Table 82. Taishan Xinning Pharmaceutical Co., Ltd. Company Information Table 83. Taishan Xinning Pharmaceutical Co., Ltd. Business Overview Table 84. Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 86. Taishan Xinning Pharmaceutical Co., Ltd. Recent Development Table 87. Xi'an Disai Biopharmaceutical Co., Ltd. Company Information Table 88. Xi'an Disai Biopharmaceutical Co., Ltd. Business Overview Table 89. Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 91. Xi'an Disai Biopharmaceutical Co., Ltd. Recent Development Table 92. North America Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Non-iodinated X-ray Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 95. North America Non-iodinated X-ray Contrast Agents Sales by Type (2027-2032) & (K Units) Table 96. North America Non-iodinated X-ray Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 97. North America Non-iodinated X-ray Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 98. North America Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Non-iodinated X-ray Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 101. North America Non-iodinated X-ray Contrast Agents Sales by Application (2027-2032) & (K Units) Table 102. North America Non-iodinated X-ray Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 103. North America Non-iodinated X-ray Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 104. North America Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Non-iodinated X-ray Contrast Agents Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 108. North America Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026) & (K Units) Table 109. North America Non-iodinated X-ray Contrast Agents Sales by Country (2027-2032) & (K Units) Table 110. North America Non-iodinated X-ray Contrast Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 111. North America Non-iodinated X-ray Contrast Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 112. United States Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 113. Canada Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 114. Mexico Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 115. Europe Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Non-iodinated X-ray Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 118. Europe Non-iodinated X-ray Contrast Agents Sales by Type (2027-2032) & (K Units) Table 119. Europe Non-iodinated X-ray Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 120. Europe Non-iodinated X-ray Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 121. Europe Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Non-iodinated X-ray Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 124. Europe Non-iodinated X-ray Contrast Agents Sales by Application (2027-2032) & (K Units) Table 125. Europe Non-iodinated X-ray Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 126. Europe Non-iodinated X-ray Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Europe Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Non-iodinated X-ray Contrast Agents Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 131. Europe Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026) & (K Units) Table 132. Europe Non-iodinated X-ray Contrast Agents Sales by Country (2027-2032) & (K Units) Table 133. Europe Non-iodinated X-ray Contrast Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 134. Europe Non-iodinated X-ray Contrast Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 135. Germany Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 136. France Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 137. U.K. Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 138. Italy Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 139. Russia Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 140. Spain Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 143. Sweden Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 144. Poland Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 145. China Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 146. China Non-iodinated X-ray Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 147. China Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 148. China Non-iodinated X-ray Contrast Agents Sales by Type (2027-2032) & (K Units) Table 149. China Non-iodinated X-ray Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 150. China Non-iodinated X-ray Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 151. China Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 152. China Non-iodinated X-ray Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 153. China Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 154. China Non-iodinated X-ray Contrast Agents Sales by Application (2027-2032) & (K Units) Table 155. China Non-iodinated X-ray Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 156. China Non-iodinated X-ray Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Asia Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Non-iodinated X-ray Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 160. Asia Non-iodinated X-ray Contrast Agents Sales by Type (2027-2032) & (K Units) Table 161. Asia Non-iodinated X-ray Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Asia Non-iodinated X-ray Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Asia Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Non-iodinated X-ray Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 166. Asia Non-iodinated X-ray Contrast Agents Sales by Application (2027-2032) & (K Units) Table 167. Asia Non-iodinated X-ray Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Asia Non-iodinated X-ray Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Non-iodinated X-ray Contrast Agents Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. Asia Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026) & (K Units) Table 174. Asia Non-iodinated X-ray Contrast Agents Sales by Country (2027-2032) & (K Units) Table 175. Asia Non-iodinated X-ray Contrast Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Asia Non-iodinated X-ray Contrast Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Japan Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 178. South Korea Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 179. India Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 180. Australia Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Non-iodinated X-ray Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 186. SAMEA Non-iodinated X-ray Contrast Agents Sales by Type (2027-2032) & (K Units) Table 187. SAMEA Non-iodinated X-ray Contrast Agents Sales Price by Type (2021-2026) & (US$/Unit) Table 188. SAMEA Non-iodinated X-ray Contrast Agents Sales Price by Type (2027-2032) & (US$/Unit) Table 189. SAMEA Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Non-iodinated X-ray Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 192. SAMEA Non-iodinated X-ray Contrast Agents Sales by Application (2027-2032) & (K Units) Table 193. SAMEA Non-iodinated X-ray Contrast Agents Sales Price by Application (2021-2026) & (US$/Unit) Table 194. SAMEA Non-iodinated X-ray Contrast Agents Sales Price by Application (2027-2032) & (US$/Unit) Table 195. SAMEA Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Non-iodinated X-ray Contrast Agents Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. SAMEA Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026) & (K Units) Table 200. SAMEA Non-iodinated X-ray Contrast Agents Sales by Country (2027-2032) & (K Units) Table 201. SAMEA Non-iodinated X-ray Contrast Agents Sales Price by Country (2021-2026) & (US$/Unit) Table 202. SAMEA Non-iodinated X-ray Contrast Agents Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Brazil Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 204. Argentina Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 205. Chile Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 206. Colombia Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 207. Peru Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 209. Israel Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 210. UAE Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 211. Turkey Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 212. Iran Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 213. Egypt Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Non-iodinated X-ray Contrast Agents Distributors List Table 217. Non-iodinated X-ray Contrast Agents Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Non-iodinated X-ray Contrast Agents Image Figure 2. Global Non-iodinated X-ray Contrast Agents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-iodinated X-ray Contrast Agents Market Size Share 2021 VS 2025 VS 2032 Figure 4. Barium Sulfate Type I Image Figure 5. Barium Sulfate Type II Image Figure 6. Global Non-iodinated X-ray Contrast Agents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Non-iodinated X-ray Contrast Agents Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Non-iodinated X-ray Contrast Agents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Non-iodinated X-ray Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 13. Global Non-iodinated X-ray Contrast Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Region (2021-2032) Figure 16. Global Non-iodinated X-ray Contrast Agents Sales (2021-2032) & (K Units) Figure 17. Global Non-iodinated X-ray Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Non-iodinated X-ray Contrast Agents Sales YoY (2021-2032) & (K Units) Figure 20. Europe Non-iodinated X-ray Contrast Agents Sales YoY (2021-2032) & (K Units) Figure 21. China Non-iodinated X-ray Contrast Agents Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Non-iodinated X-ray Contrast Agents Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Non-iodinated X-ray Contrast Agents Sales YoY (2021-2032) & (K Units) Figure 24. Global Non-iodinated X-ray Contrast Agents Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Non-iodinated X-ray Contrast Agents Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Non-iodinated X-ray Contrast Agents Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Type (2021-2032) Figure 30. Global Non-iodinated X-ray Contrast Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Type (2021-2032) Figure 33. Global Non-iodinated X-ray Contrast Agents Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Application (2021-2032) Figure 36. Global Non-iodinated X-ray Contrast Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Application (2021-2032) Figure 39. North America Non-iodinated X-ray Contrast Agents Revenue Share by Type (2021-2032) Figure 40. North America Non-iodinated X-ray Contrast Agents Sales Share by Type (2021-2032) Figure 41. North America Non-iodinated X-ray Contrast Agents Revenue Share by Application (2021-2032) Figure 42. North America Non-iodinated X-ray Contrast Agents Sales Share by Application (2021-2032) Figure 43. North America Non-iodinated X-ray Contrast Agents Revenue Share by Country (2021-2032) Figure 44. North America Non-iodinated X-ray Contrast Agents Sales Share by Country (2021-2032) Figure 45. Europe Non-iodinated X-ray Contrast Agents Revenue Share by Type (2021-2032) Figure 46. Europe Non-iodinated X-ray Contrast Agents Sales Share by Type (2021-2032) Figure 47. Europe Non-iodinated X-ray Contrast Agents Revenue Share by Application (2021-2032) Figure 48. Europe Non-iodinated X-ray Contrast Agents Sales Share by Application (2021-2032) Figure 49. Europe Non-iodinated X-ray Contrast Agents Revenue Share by Country (2021-2032) Figure 50. Europe Non-iodinated X-ray Contrast Agents Sales Share by Country (2021-2032) Figure 51. China Non-iodinated X-ray Contrast Agents Revenue Share by Type (2021-2032) Figure 52. China Non-iodinated X-ray Contrast Agents Sales Share by Type (2021-2032) Figure 53. China Non-iodinated X-ray Contrast Agents Revenue Share by Application (2021-2032) Figure 54. China Non-iodinated X-ray Contrast Agents Sales Share by Application (2021-2032) Figure 55. Asia Non-iodinated X-ray Contrast Agents Revenue Share by Type (2021-2032) Figure 56. Asia Non-iodinated X-ray Contrast Agents Sales Share by Type (2021-2032) Figure 57. Asia Non-iodinated X-ray Contrast Agents Revenue Share by Application (2021-2032) Figure 58. Asia Non-iodinated X-ray Contrast Agents Sales Share by Application (2021-2032) Figure 59. Asia Non-iodinated X-ray Contrast Agents Revenue Share by Country (2021-2032) Figure 60. Asia Non-iodinated X-ray Contrast Agents Sales Share by Country (2021-2032) Figure 61. SAMEA Non-iodinated X-ray Contrast Agents Revenue Share by Type (2021-2032) Figure 62. SAMEA Non-iodinated X-ray Contrast Agents Sales Share by Type (2021-2032) Figure 63. SAMEA Non-iodinated X-ray Contrast Agents Revenue Share by Application (2021-2032) Figure 64. SAMEA Non-iodinated X-ray Contrast Agents Sales Share by Application (2021-2032) Figure 65. SAMEA Non-iodinated X-ray Contrast Agents Revenue Share by Country (2021-2032) Figure 66. SAMEA Non-iodinated X-ray Contrast Agents Sales Share by Country (2021-2032) Figure 67. Non-iodinated X-ray Contrast Agents Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Non-iodinated X-ray Contrast Agents Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Barium Sulfate Type I
  • Barium Sulfate Type II
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Bracco Diagnostics
  • Guerbet Group
  • Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
  • Qingdao Hongdie New Materials Co., Ltd.
  • Shandong Shengli Pharmaceutical Co., Ltd.
  • Taishan Xinning Pharmaceutical Co., Ltd.
  • Xi'an Disai Biopharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-iodinated X-ray Contrast Agents Market by Type
  3. 1.2.1 Global Non-iodinated X-ray Contrast Agents Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Barium Sulfate Type I
  5. 1.2.3 Barium Sulfate Type II
  6. 1.3 Non-iodinated X-ray Contrast Agents Market by Application
  7. 1.3.1 Global Non-iodinated X-ray Contrast Agents Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Non-iodinated X-ray Contrast Agents Market Dynamics
  1. 2.1 Non-iodinated X-ray Contrast Agents Industry Trends
  2. 2.2 Non-iodinated X-ray Contrast Agents Industry Drivers
  3. 2.3 Non-iodinated X-ray Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Non-iodinated X-ray Contrast Agents Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Non-iodinated X-ray Contrast Agents Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Non-iodinated X-ray Contrast Agents Revenue by Region
  3. 3.2.1 Global Non-iodinated X-ray Contrast Agents Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-iodinated X-ray Contrast Agents Revenue by Region (2021-2026)
  5. 3.2.3 Global Non-iodinated X-ray Contrast Agents Revenue by Region (2027-2032)
  6. 3.2.4 Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Non-iodinated X-ray Contrast Agents Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Non-iodinated X-ray Contrast Agents Sales by Region
  9. 3.4.1 Global Non-iodinated X-ray Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Non-iodinated X-ray Contrast Agents Sales by Region (2021-2026)
  11. 3.4.3 Global Non-iodinated X-ray Contrast Agents Sales by Region (2027-2032)
  12. 3.4.4 Global Non-iodinated X-ray Contrast Agents Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Non-iodinated X-ray Contrast Agents Revenue by Manufacturers
  2. 4.1.1 Global Non-iodinated X-ray Contrast Agents Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Non-iodinated X-ray Contrast Agents Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-iodinated X-ray Contrast Agents Sales by Manufacturers
  6. 4.2.1 Global Non-iodinated X-ray Contrast Agents Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Non-iodinated X-ray Contrast Agents Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Non-iodinated X-ray Contrast Agents Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Non-iodinated X-ray Contrast Agents Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Non-iodinated X-ray Contrast Agents Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Non-iodinated X-ray Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Non-iodinated X-ray Contrast Agents Manufacturers, Product Type & Application
  13. 4.7 Global Non-iodinated X-ray Contrast Agents Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Non-iodinated X-ray Contrast Agents Market CR5 and HHI
  16. 4.8.2 2025 Non-iodinated X-ray Contrast Agents Tier 1, Tier 2, and Tier 3
5 Non-iodinated X-ray Contrast Agents Market by Type
  1. 5.1 Global Non-iodinated X-ray Contrast Agents Revenue by Type
  2. 5.1.1 Global Non-iodinated X-ray Contrast Agents Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Non-iodinated X-ray Contrast Agents Sales by Type
  6. 5.2.1 Global Non-iodinated X-ray Contrast Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-iodinated X-ray Contrast Agents Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Non-iodinated X-ray Contrast Agents Sales Market Share by Type (2021-2032)
  9. 5.3 Global Non-iodinated X-ray Contrast Agents Price by Type
6 Non-iodinated X-ray Contrast Agents Market by Application
  1. 6.1 Global Non-iodinated X-ray Contrast Agents Revenue by Application
  2. 6.1.1 Global Non-iodinated X-ray Contrast Agents Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Non-iodinated X-ray Contrast Agents Sales by Application
  6. 6.2.1 Global Non-iodinated X-ray Contrast Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Non-iodinated X-ray Contrast Agents Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Non-iodinated X-ray Contrast Agents Sales Market Share by Application (2021-2032)
  9. 6.3 Global Non-iodinated X-ray Contrast Agents Price by Application
7 Company Profiles
  1. 7.1 Bracco Diagnostics
  2. 7.1.1 Bracco Diagnostics Company Information
  3. 7.1.2 Bracco Diagnostics Business Overview
  4. 7.1.3 Bracco Diagnostics Non-iodinated X-ray Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bracco Diagnostics Non-iodinated X-ray Contrast Agents Product Portfolio
  6. 7.1.5 Bracco Diagnostics Recent Developments
  7. 7.2 Guerbet Group
  8. 7.2.1 Guerbet Group Company Information
  9. 7.2.2 Guerbet Group Business Overview
  10. 7.2.3 Guerbet Group Non-iodinated X-ray Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Guerbet Group Non-iodinated X-ray Contrast Agents Product Portfolio
  12. 7.2.5 Guerbet Group Recent Developments
  13. 7.3 Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
  14. 7.3.1 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  18. 7.3.5 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Qingdao Hongdie New Materials Co., Ltd.
  20. 7.4.1 Qingdao Hongdie New Materials Co., Ltd. Company Information
  21. 7.4.2 Qingdao Hongdie New Materials Co., Ltd. Business Overview
  22. 7.4.3 Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  24. 7.4.5 Qingdao Hongdie New Materials Co., Ltd. Recent Developments
  25. 7.5 Shandong Shengli Pharmaceutical Co., Ltd.
  26. 7.5.1 Shandong Shengli Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Shandong Shengli Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  30. 7.5.5 Shandong Shengli Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Taishan Xinning Pharmaceutical Co., Ltd.
  32. 7.6.1 Taishan Xinning Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Taishan Xinning Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  36. 7.6.5 Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Xi'an Disai Biopharmaceutical Co., Ltd.
  38. 7.7.1 Xi'an Disai Biopharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Xi'an Disai Biopharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  42. 7.7.5 Xi'an Disai Biopharmaceutical Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Non-iodinated X-ray Contrast Agents Market Size by Type
  2. 8.1.1 North America Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2032)
  3. 8.1.2 North America Non-iodinated X-ray Contrast Agents Sales by Type (2021-2032)
  4. 8.1.3 North America Non-iodinated X-ray Contrast Agents Price by Type (2021-2032)
  5. 8.2 North America Non-iodinated X-ray Contrast Agents Market Size by Application
  6. 8.2.1 North America Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2032)
  7. 8.2.2 North America Non-iodinated X-ray Contrast Agents Sales by Application (2021-2032)
  8. 8.2.3 North America Non-iodinated X-ray Contrast Agents Price by Application (2021-2032)
  9. 8.3 North America Non-iodinated X-ray Contrast Agents Market Size by Country
  10. 8.3.1 North America Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Non-iodinated X-ray Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Non-iodinated X-ray Contrast Agents Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Non-iodinated X-ray Contrast Agents Market Size by Type
  2. 9.1.1 Europe Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2032)
  3. 9.1.2 Europe Non-iodinated X-ray Contrast Agents Sales by Type (2021-2032)
  4. 9.1.3 Europe Non-iodinated X-ray Contrast Agents Price by Type (2021-2032)
  5. 9.2 Europe Non-iodinated X-ray Contrast Agents Market Size by Application
  6. 9.2.1 Europe Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2032)
  7. 9.2.2 Europe Non-iodinated X-ray Contrast Agents Sales by Application (2021-2032)
  8. 9.2.3 Europe Non-iodinated X-ray Contrast Agents Price by Application (2021-2032)
  9. 9.3 Europe Non-iodinated X-ray Contrast Agents Market Size by Country
  10. 9.3.1 Europe Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Non-iodinated X-ray Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Non-iodinated X-ray Contrast Agents Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Non-iodinated X-ray Contrast Agents Market Size by Type
  2. 10.1.1 China Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2032)
  3. 10.1.2 China Non-iodinated X-ray Contrast Agents Sales by Type (2021-2032)
  4. 10.1.3 China Non-iodinated X-ray Contrast Agents Price by Type (2021-2032)
  5. 10.2 China Non-iodinated X-ray Contrast Agents Market Size by Application
  6. 10.2.1 China Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2032)
  7. 10.2.2 China Non-iodinated X-ray Contrast Agents Sales by Application (2021-2032)
  8. 10.2.3 China Non-iodinated X-ray Contrast Agents Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-iodinated X-ray Contrast Agents Market Size by Type
  2. 11.1.1 Asia Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2032)
  3. 11.1.2 Asia Non-iodinated X-ray Contrast Agents Sales by Type (2021-2032)
  4. 11.1.3 Asia Non-iodinated X-ray Contrast Agents Price by Type (2021-2032)
  5. 11.2 Asia Non-iodinated X-ray Contrast Agents Market Size by Application
  6. 11.2.1 Asia Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2032)
  7. 11.2.2 Asia Non-iodinated X-ray Contrast Agents Sales by Application (2021-2032)
  8. 11.2.3 Asia Non-iodinated X-ray Contrast Agents Price by Application (2021-2032)
  9. 11.3 Asia Non-iodinated X-ray Contrast Agents Market Size by Country
  10. 11.3.1 Asia Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Non-iodinated X-ray Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Non-iodinated X-ray Contrast Agents Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-iodinated X-ray Contrast Agents Market Size by Type
  2. 12.1.1 SAMEA Non-iodinated X-ray Contrast Agents Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Non-iodinated X-ray Contrast Agents Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Non-iodinated X-ray Contrast Agents Price by Type (2021-2032)
  5. 12.2 SAMEA Non-iodinated X-ray Contrast Agents Market Size by Application
  6. 12.2.1 SAMEA Non-iodinated X-ray Contrast Agents Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Non-iodinated X-ray Contrast Agents Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Non-iodinated X-ray Contrast Agents Price by Application (2021-2032)
  9. 12.3 SAMEA Non-iodinated X-ray Contrast Agents Market Size by Country
  10. 12.3.1 SAMEA Non-iodinated X-ray Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Non-iodinated X-ray Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Non-iodinated X-ray Contrast Agents Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Non-iodinated X-ray Contrast Agents Value Chain Analysis
  2. 13.1.1 Non-iodinated X-ray Contrast Agents Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Non-iodinated X-ray Contrast Agents Production Mode & Process
  6. 13.2 Non-iodinated X-ray Contrast Agents Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Non-iodinated X-ray Contrast Agents Distributors
  9. 13.2.3 Non-iodinated X-ray Contrast Agents Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst